↓ Skip to main content

New Approaches to Overcome Transport Related Drug Resistance in Trypanosomatid Parasites

Overview of attention for article published in Frontiers in Pharmacology, September 2016
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
114 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
New Approaches to Overcome Transport Related Drug Resistance in Trypanosomatid Parasites
Published in
Frontiers in Pharmacology, September 2016
DOI 10.3389/fphar.2016.00351
Pubmed ID
Authors

Jose A. Garcia-Salcedo, Juan D. Unciti-Broceta, Javier Valverde-Pozo, Miguel Soriano

Abstract

Leishmania and Trypanosoma are members of the Trypanosomatidae family that cause severe human infections such as leishmaniasis, Chagas disease, and sleeping sickness affecting millions of people worldwide. Despite efforts to eradicate them, migrations are expanding these infections to developing countries. There are no vaccines available and current treatments depend only on chemotherapy. Drug resistance is a major obstacle for the treatment of these diseases given that existing drugs are old and limited, with some having severe side effects. Most resistance mechanisms developed by these parasites are related with a decreased uptake or increased efflux of the drug due to mutations or altered expression of membrane transporters. Different new approaches have been elaborated that can overcome these mechanisms of resistance including the use of inhibitors of efflux pumps and drug carriers for both active and passive targeting. Here we review new formulations that have been successfully applied to circumvent resistance related to drug transporters, opening alternative ways to solve drug resistance in protozoan parasitic diseases.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 114 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Argentina 1 <1%
Brazil 1 <1%
Unknown 112 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 18 16%
Student > Ph. D. Student 14 12%
Student > Bachelor 13 11%
Researcher 11 10%
Student > Doctoral Student 11 10%
Other 18 16%
Unknown 29 25%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 28 25%
Agricultural and Biological Sciences 16 14%
Medicine and Dentistry 9 8%
Immunology and Microbiology 6 5%
Veterinary Science and Veterinary Medicine 5 4%
Other 18 16%
Unknown 32 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 September 2016.
All research outputs
#20,342,896
of 22,889,074 outputs
Outputs from Frontiers in Pharmacology
#10,123
of 16,187 outputs
Outputs of similar age
#279,780
of 322,616 outputs
Outputs of similar age from Frontiers in Pharmacology
#92
of 158 outputs
Altmetric has tracked 22,889,074 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,187 research outputs from this source. They receive a mean Attention Score of 4.9. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 322,616 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 158 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.